Basit öğe kaydını göster

Visible Light Detection of Dopamine Enhanced by Cloud Point Extraction

dc.contributor.authorFilik, Hayati
dc.contributor.authorAvan, Asiye Aslihan
dc.date.accessioned2021-03-06T13:10:33Z
dc.date.available2021-03-06T13:10:33Z
dc.date.issued2019
dc.identifier.citationAvan A. A. , Filik H., "Visible Light Detection of Dopamine Enhanced by Cloud Point Extraction", CURRENT PHARMACEUTICAL ANALYSIS, cilt.15, ss.528-534, 2019
dc.identifier.issn1573-4129
dc.identifier.otherav_f75c693c-7d2b-4f2b-a40b-78e6a5522c70
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/162056
dc.identifier.urihttps://doi.org/10.2174/1573412914666180427152544
dc.description.abstractBackground: Monitoring of DA, in the presence of other chemical analogues such as epinephrine, norepinephrine, serotonin, ascorbic acid, uric acid, catechol, phenethylamine, tyramine, and tyrosine, is crucial in the diagnosis and mechanistic understanding of human neuropathology. Therefore, the determination of DA at trace levels has become a very important analytical task, as part of health safety and forensic analysis.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleVisible Light Detection of Dopamine Enhanced by Cloud Point Extraction
dc.typeMakale
dc.relation.journalCURRENT PHARMACEUTICAL ANALYSIS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume15
dc.identifier.issue5
dc.identifier.startpage528
dc.identifier.endpage534
dc.contributor.firstauthorID260007


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster